DARE bullish upcoming catalysts in 2021 and 2022
Mis à jour
No Investment advice!
Only for practicing.
Interessting volume spikes in the past.
Upcoming Catalsyst:
DARE-BV1
Bacterial Vaginosis
1H 2021 Phase 3 trial met primary endpoint - December 7, 2020. NDA planned for 1H 2021.
*Phase 1
DARE-HRT1
Hormone replacement therapy
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*Phase 2b
Sildenafil Cream, 3.6%
Female Sexual Arousal Disorder (FSAD)
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*
Phase 3
Ovaprene
Contraception
2022 Pivotal trial data due in 2022.
Only for practicing.
Interessting volume spikes in the past.
Upcoming Catalsyst:
DARE-BV1
Bacterial Vaginosis
1H 2021 Phase 3 trial met primary endpoint - December 7, 2020. NDA planned for 1H 2021.
*Phase 1
DARE-HRT1
Hormone replacement therapy
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*Phase 2b
Sildenafil Cream, 3.6%
Female Sexual Arousal Disorder (FSAD)
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*
Phase 3
Ovaprene
Contraception
2022 Pivotal trial data due in 2022.
Note
Trade fermée: cible de profit atteinte
nice spike! Hit my Target
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.